ClinicalTrials.gg
RecruitingNCT06820892EVIDANCEUpdated Feb 11, 2025

Quality of Information Provided During Antenatal Consultations

An observational study in Congenital Anomalies, Prematurity and Antenatal Consultation, sponsored by Hospices Civils de Lyon. Recruiting at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-11.

Primary conditionCongenital Abnormalities(the registry's first term)UnverifiedIs this wrong?Congenital Abnormalities is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by Hospices Civils de Lyon · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 8 months ago, but the record still lists the study as recruiting.
  • Started Aug 2024; still recruiting 2 years 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
113
Ages
18 Years and older
Sex
Female
01

Study summary

The objective of this questionnaire study is to evaluate the concordance between the information provided to parents during antenatal consultations and their subsequent experiences following childbirth.

02

Conditions studied

  • Congenital Anomalies
  • Prematurity
  • Antenatal Consultation

Browse trials for

Keywords

  • Antenatal
  • Antenatal consultation
  • information
03

In context

Congenital Abnormalities Unverified

782 studies on the registry are indexed under Congenital Abnormalities; 78 are open to participants now.

This study's planned enrollment of 113 is below the median of 248 across 258 observational studies indexed under Congenital Abnormalities.

Browse Congenital Abnormalities studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,868 studies on the registry; 447 are open to participants now.

Compared within Congenital Abnormalities, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Of the patients who were followed up at the multidisciplinary prenatal diagnosis centre and had an antenatal consultation with a pediatric neonatologist, 113 patients met the inclusion criteria.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients were observed at the multidisciplinary prenatal diagnosis centre.
  • Patients who had attended at least one antenatal consultation with a pediatric neonatologist
  • Patients who gave birth between January 2020 and December 2022 and whose newborn was hospitalized in the neonatology department

Exclusion criteria

Exclusion Criteria:

  • a child who died in hospital or had a condition with a high risk of death in the first few years of life
  • non-French speaking mothers
  • Mothers who were minors at the time of the study
05

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
113 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients (mother only)

    The patients were observed in a multidisciplinary prenatal diagnosis centre and subsequently delivered a newborn infant, who was then admitted to the neonatology department of the same hospital, between January 2020 and December 2022.

    Other: Survey

Interventions

  • OtherSurvey

    The study utilised a 16-item questionnaire to evaluate the quality of information received during antenatal diagnosis consultations and its congruence with subsequent experiences following birth and hospitalisation of the infant. The questionnaire encompassed seven questions pertaining to consultation arrangements, including duration, frequency and unit visits, six questions addressing the received information, and three questions exploring the long-term outcomes of the child.

06

What researchers measure

Primary outcomes

  1. Question 8 of the questionnaire

    In summary, did the information provided during the consultation with the paediatrician correspond to the events that transpired during your child's hospitalisation ? Patients are invited to indicate their level of agreement or disagreement with a series of four statements by selecting one of four options : 'not at all', 'to some extent', 'almost' or 'completely'.

    Time frame: The outcome is measured at the time of questionnaire completion, typically at hospital discharge or within one week post-discharge.

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Aug 2024 (actual). Primary completion is estimated for Mar 2025, 6 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 5, 2025
First posted
Feb 11, 2025
StartActual
Aug 2, 2024
Primary completionEst.
Mar 1, 2025
CompletionEst.
Mar 15, 2025
Last update
Feb 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06820892
Responsible party
Sponsor
First posted
Feb 11, 2025
Start date
Aug 2, 2024
Primary completion
Mar 1, 2025 (estimated)
Completion
Mar 15, 2025 (estimated)
Last update
Feb 11, 2025

Study contacts

Cosima BABINET
Contact
cosima.babinet@chu-lyon.fr
+33608161034

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion